Updated:
Astex Pharmaceuticals
Astex Pharmaceuticals is a corporate investor based in Cambridge, founded 1991; the Altss profile covers its classification, headquarters, registration, AUM...
Astex Pharmaceuticals
Astex Pharmaceuticals Inc. is a corporate investor based in Cambridge, UK. It invests in 1 fund. The firm focuses on European markets.
General information
Firm type
Corporate Investor
Year founded
1991
AUM
Undisclosed
Location
Region
Europe
Country
United Kingdom
City
Cambridge
Corporate office
Cambridge, United Kingdom
Additional offices
Dublin, CA, United States
Sector focus
Frequently asked questions
Who runs investment decisions at Astex Pharmaceuticals?
Investment decisions sit inside Otsuka Pharmaceutical’s oncology group following the 2013 acquisition. No separate CIO or investment committee is disclosed.
Does Astex participate in fund commitments or only direct deals?
Activity centers on direct equity positions, co-development agreements, and platform licensing rather than third-party fund commitments.
What investment stages does Astex typically target?
The firm targets early-stage venture opportunities in oncology and related biology through its Pyramid discovery platform.
Which sectors does Astex explicitly avoid?
No explicit avoidance list is published. Activity remains concentrated in oncology and select neurodegenerative programs via the Dementia Consortium.
How is Astex related to Otsuka Pharmaceutical?
Otsuka acquired Astex in 2013 for approximately $886 million and continues to own the entity outright.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: